作为重度预先治疗的转移性肉 Sarcoma 患者的救援疗法的单剂temozolomide

Izzet Dogan1, Nail Paksoy, Mert Basaran

  • 1Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey.

概括

泰莫佐洛米德的疗效有限,但在预先治疗的转移性软组织肉瘤患者中耐受性良好. 它可以被认为是一个单剂的选择,广泛治疗的个人.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K